background: We previously established parthenogenetic mouse embryonic stem cells (ESCs) and this study was subsequently conducted for elucidating the influence of oocyte parthenogenesis on gene expression profile of ESCs.
Introduction
Successful cell replacement therapy requires either establishing immune-specific pluripotent cell lines or acquiring immune tolerance in heterogeneous stem cells. To eliminate the risk of cloning in autologous stem cell therapy and to efficiently establish immune-specific stem cells, various alternatives to somatic cell nuclear transfer have been suggested (Cowan et al., 2005; Chung et al., 2006; Meissner and Jaenisch, 2006; Okita et al., 2007; Wernig et al., 2007) . Using a mouse model, we have previously established autologous embryonic stem cells (ESCs) by parthenogenetic activation of oocytes , and the physiological and genetic properties of the parthenogenetic ESC (pESC) lines have been characterized . To confirm clinical feasibility of pESCs established, it is absolutely necessary to evaluate alteration of genetic and cellular properties after parthenogenesis. Unfortunately, there was no report on evaluating difference in gene expression in pESCs.
In this study, we made two sets of comparison using pESC-1 and pESC-2 lines. In each comparison, we first compared the gene expression between normally fertilized ESCs (nfESCs) of B6D2F1 (C57BL/6 X DBA2) strain (established from our laboratory) and those of R1 (129X1 Â 129S1) strain (commercially purchased from ATCC) in mice. Second, comparison was subsequently made between B6D2F1 pESCs (pESC-1 for the first and pESC-2 line for the second comparison) and nfESCs of the same strain, and between B6D2F1 pESC-1 or pESC-2 and nfESCs of R1 strain. Using a microarray Genechip technology and a gene network map, genes being up-regulated or down-regulated after parthenogenesis were identified. Gene ontogeny annotation was performed for assuming changes in cellular function after parthenogenesis and real-time PCR analysis was conducted to verify the microarray results. As additional analyses, major regulatory hub genes were identified in the comparisons between pESCs and nfESCs.
Materials and Methods

Preparation of mouse blastocysts fertilized in vivo
All procedures for animal management, breeding and surgery followed the standard protocols of Seoul National University. Appropriate management of experimental samples and quality control of the laboratory facility and equipment were also conducted. The Institutional Animal Care and Use Committee, Seoul National University, approved our research proposal in April 2005 (approval number: SNU0050331-02). The B6D2F1 hybrid strain, produced by the mating of a female C57BL/6 with a male DBA2, was maintained under controlled lighting (14 h Light:10 h Dark), temperature (20-228C) and humidity (40-60%). Naturally ovulated females in estrus were then mated naturally, and we collected blastocysts by uterine flushing 72 h after mating. The flushing medium was M2 medium consisting of 94.7 mM NaCl, 4.8 mM KCl, 1.7 mM CaCl 2 . 2H 2 O, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 . 7H 2 O, 4.2 mM NaHCO 3 , 20.9 mM HEPES, 23.3 mM sodium lactate, 0.3 mM sodium pyruvate, 5.6 mM glucose, 1% (v/v) penicillin/streptomycin solution and 4 mg/ml bovine serum albumin (BSA). All medium substrates were purchased from Sigma-Aldrich Corp. (St Louis, MO, USA) unless otherwise stated.
Collection of mature oocytes and production of blastocysts after parthenogenetic activation
Ovulated oocytes were collected by oviduct flushing of naturally ovulated F1 females in estrus 15 h after mating with a vasectomized male. Maturation of the oocytes to the metaphase II stage was determined by extrusion of the first polar body and expansion of cumulus cells. Oocytes were freed from cumulus cells by placement in M2 medium supplemented with hyaluronidase (200 units/ml) for 5 min at 378C. The oocytes were then activated by culture in Ca 2+ -free KSOM medium supplemented with 10 mM SrCl 2 and 5 mg/ml cytochalasin B for 4 h. Modified Chatot, Ziomek and Bavister medium consisting of 81.6 mM NaCl, 4.8 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 . 7H 2 O, 1.7 mM CaCl 2 . 2H 2 O, 25.1 mM NaHCO 3 , 31.3 mM sodium lactate, 0.3 mM sodium pyruvate, 1 mM glutamine, 0.1 mM EDTA and 5 mg/ml BSA, to which 0.001 mg/ml Hb (methemoglobin) and 5.5 mM b-mercaptoethanol (Gibco Invitrogen, Grand Island, NY, USA) were added, was used for culturing parthenogenetically activated oocytes. Activated oocytes were cultured in a 5-ml droplet of the medium overlaid with washed mineral oil at 378C in an atmosphere containing 5% CO 2 . Blastocysts obtained were used for ESC establishment.
Establishment and culture of ESCs
The zona pellucida of blastocysts derived from normal fertilization and parthenogenesis were removed using acid Tyrode's solution, and the zona-free blastocysts were subsequently cultured on a feeder layer of mouse embryonic fibroblasts (MEFs) treated with 10 mg/ml mitomycin C (Chemicon, Temecula, CA, USA) for 3 h in gelatin-coated 4-well multi-dishes. Knock-out Dulbecco's minimal essential medium (KDMEM; Gibco Invitrogen) supplemented with 0.1 mM b-mercaptoethanol (Gibco Invitrogen), 1% (v/v) non-essential amino acids (Gibco Invitrogen), 2 mM L-glutamine, 1% (v/v) mixture of penicillin and streptomycin, 2000 units/ml mouse leukemia inhibitory factor (LIF; Chemicon), and a 3:1 mixture of fetal bovine serum (FBS) and knock-out serum replacement was used for initial culture of the blastocysts. On Day 4 of culture, inner cell mass cell-derived cell colonies were mechanically removed with a capillary pipette and replated on MEF feeder cells for further expansion. Expanded colonies were dissociated with 0.04% (w/v) trypsin-EDTA (Gibco Invitrogen) and subcultured on a 35-mm tissue culture dish in the presence of MEF feeder cells under a humidified atmosphere of 5% CO 2 at 378C. After colony expansion, the LIF concentration in ESC culture media was reduced to 1000 units/ml, and subpassage was conducted at intervals of 4 days, when the cultured ESCs had reached 70 -80% confluency. The medium was changed daily during subculture. R1 nfESCs purchased from ATCC were subpassaged with the standard protocols of our laboratory .
Characterization of established ESCs
For characterization using stem cell-specific markers, ESCs collected at the 20th subpassage were fixed in 4% (v/v) formaldehyde (Sigma-Aldrich) at room temperature for 10 min. To confirm spontaneous differentiation in vitro, the ESCs were treated with 0.04% (v/v) trypsin-EDTA (Gibco Invitrogen), and the dissociated cells were subsequently transferred to 100-mm plastic Petri dishes that contained LIF-free DMEM (Gibco Invitrogen) that was supplemented with 10% (v/v) FBS. The cells were grown until the embryoid bodies (Ebs) formed. The EBs were seeded separately into 4-well culture plates and cultured for 10 -14 days. The EBs were stained with the following specific markers for the three germ layers: nestin (Santa Cruz Biotechnology) and S-100 (Biodesign International, Saco, ME) for ectodermal cells; muscle actin (Biodesign International) and desmin (Santa Cruz Biotechnology) for mesodermal cells and a-fetoprotein (Biodesign International) and troma-1 (Developmental Studies Hybridoma Bank) for endodermal cells. Antibody localization was performed with the DakoCytomation kit (DakoCytomation). For monitoring ESC capacity to differentiate in vivo, 1Â10 7 ESCs retrieved at the 20th subpassage were injected s.c. into adult NOD-SCID (non-obese diabetic/severely compromised immunodeficient) mice. Teratomas that formed in the subcutaneous region were collected 8 weeks post-transplantation and fixed with 4% (v/v) paraformaldehyde (Sigma-Aldrich). After embedding in paraffin blocks, the tissues were stained with hematoxylin and eosin for examination under a phase-contrast microscope (BX51TF; Olympus, Kogaku, Japan).
Generation of Affymetrix chip data
All analyses were performed in triplicate. The generation of Affymetrix data from the three different stem cell samples was performed by Seoulin Bioscience Cooperation (Seoul, Korea). About 4 mg of total RNA from the samples were used for labeling. Probe synthesis from total RNA samples, hybridization, detection and scanning were performed according to standard protocols from Affymetrix, Inc. (Santa Clara, CA, USA). Briefly, complementary DNA (cDNA) was synthesized using the One-Cycle cDNA Synthesis Kit (Affymetrix). Single-stranded cDNA was synthesized using Superscript II reverse transcriptase and T7-oligo (dT) primers at 428C for 1 h. Double-stranded (ds) cDNA was obtained using DNA ligase, DNA polymerase I and RNase H at 168C for 2 h, followed by T4 DNA polymerase at 168C for 5 min. After cleanup with a Sample Cleanup Module (Affymetrix), ds-cDNA was used for in vitro transcription (IVT). cDNA was transcribed using the Affymetrix GeneChip w IVT Labeling Kit in the presence of biotin-labeled CTP and UTP. The biotin-labeled IVT-RNA was then fragmented. Fragmented cRNA was hybridized to the Mouse Genome 430 2.0 Array, which has 45 000 gene probes for over 34 000 well-characterized mouse genes, at 458C for 16 h according to the manufacturer's instructions. After hybridization, the arrays were washed in a GeneChip w Fluidics Station 450 with a nonstringent wash buffer at 258C followed by a stringent wash buffer at 508C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner, which was controlled by GeneChip w Operating Software (Affymetrix).
Analysis of DNA microarrays
The quality of the array image was assessed as described in the Affymetrix GeneChip expression analysis manual. All arrays were processed by robust multi-array average (RMA) using the R package Affy. Expression values were computed in detail from raw CEL files by applying the RMA model of the probe-specific correction of perfect-match probes. These corrected probe values were then normalized via quantile normalization, and a median polish was applied to compute one expression measure from all probe values. The resulting RMA expression values were log 2 -transformed. The individual gene expression levels were compared using an unpaired Welch t-test. The Benjamin -Hochberg correction for false discovery rate (FDR) was used for all probe-level normalized data. We selected differentially expressed genes (DEGs) that met a FDR-adjusted P-value of less than 0.05 (compatible with a 1.2-to 1.4-fold difference in gene expression) using an unpaired Welch t-test. The gene ontology annotation was conducted using the NetAffy tool (http://www.affymetrix.com) and DAVID bioinformatics resources (http://david.abcc.ncifcrf.gov).
Construction of reference gene network
Data set consisting of 180 Affymetrix GeneChip Murine Genome U74 Version 2 Set MG-U74A Array data that were derived from six different tissues (skeletal muscle, heart, fetal heart, myoblast, bone marrow, lung and skin) were used. Relative expression intensity (log 2 -transformed) for microarray data for all probes was estimated using the RMA algorithm within the 'affy' package in Bioconductor (Irizarry et al., 2003) , which performs background correction, normalization, probe-specific correction and summary. The Pearson correlation coefficients obtained for all pairwise comparisons of the expression data were then converted into a coexpression matrix by defining a similarity matrix function, which is a signum function with a thresholding parameter t.
Nodes and edges for the DEGs were identified using this signum function, where t was 0.7. The gene-coexpression network was visualized using the Cytoscape spring-embedded layout algorithm (Shannon et al., 2003) .
Quantitative real-time PCR
Primary3 software (Whitehead Institute/MIT Center for Genome Research, Cambridge, MA, USA) was used to design all specific primers used in these experiments. All PCR primers were designed based on mouse cDNA sequences obtained from GenBank. The primer sequences and annealing temperatures are listed in Supplementary data, S1. Total RNA was extracted from each sample using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. cDNA was synthesized from 1 mg of each RNA sample using the Reverse Transcription System (Promega, Madison, WI, USA). Subsequently, the expression of specific genes in each sample was quantified by real-time PCR using the DyNAmo HS SYBRGreen qPCR Kit (Finnzymes, Espoo, Finland). PCR amplification was performed in a final volume of 25 ml using the ABI PRISM 7700 sequence detection system (Applied Biosystems) with the following cycling parameters: 2 min at 508C, 15 min at 958C, followed by 40 cycles of 15 s at 958C, 30 s at 608C and 1 min at 728C. A dissociation curve was recorded to check the specificity of the amplification. The final optimized concentration of each primer was 300 nM, and the absence of inter-and/or intra-molecular duplex formation between the primers was confirmed in a control realtime PCR run that lacked a template. The mRNA level of each gene in the samples was normalized to that of b-actin. The relative mRNA level was defined as 2 2DDCt , where Ct = the threshold cycle for target amplification, DCt = Ct target gene 2Ct internal reference (b-actin) and DDCt = DCt sample 2DCt calibrator .
Results
Before analysis, the ESC lines used for this study were characterized with our standard protocols. The nfESC, pESC-1 and pESC-2 of B6D2F1 line were characterized by ESC-specific markers for alkaline phosphatase (+), and anti-SSEA-1 (+), SSEA-3 (2), SSEA-4 (2), Oct-4 (+), integrin a6 (+) and integrin b1 (+) antibodies, in vitrodifferentiation into the EB, and in vivo-differentiation into teratomas (Fig. 1) .
Analysis of microarray data
In the first set of comparisons, we monitored the number of genes (gene probes) differentially expressed between B6D2F1 nfESCs and R1 nfESCs, between B6D2F1 pESCs-1 and R1 nfESCs, and B6D2F1 pESCs-1 and B6D2F1 nfESCs (Fig. 2) . Of total 45 000 gene probes monitored, the expression of 15 750, 14 187 and 11 347 probes changed, respectively, and a gradual decrease in the number was detected as variables (strain and origin) between nfESCs and pESCs were reduced (B6D2F1 nfESCs versus B6D2F1 pESCs ,R1 nfESCs versus B6D2F1 pESCs). In all three comparisons, 4984 gene probes were simultaneously changed. In the second comparison consisting of the same procedure except for using of pESC-2, the expression of 14 944, 15 381 and 15 454 gene probes were different, respectively. Total 5391 gene probes were simultaneously changed in all comparisons. Level of correlation in each comparison was subsequently monitored to statistically evaluate the extent of the change after parthenogenesis. As shown in Fig. 3 , overall levels in each replicate of comparisons were higher in the comparisons between normal fertilization (B6D2F1 nfESCs) and parthenogenesis (B6D2F1 pESCs) than in the comparisons between strains (R1 nfESCs and B6D2F1 nfESCs) (0.974-0.985 versus 0.97 -0.971). Consequently, for each probe set we determined the genes showing different expression between pESCs and nfESCs (Table I ). In the comparison of B6D2F1 pESCs-1 versus nfESCs of the same strain, 7776 genes showed significantly altered expression after parthenogenesis. Of those, 53% (4096 genes) were up-regulated in pESCs-1, whereas the rest were down-regulated. The number of genes that had significantly different expression after parthenogenesis increased when pESCs-1 were compared with nfESCs of different strain (R1). In total, 8943 genes were expressed differently in pESCs-1 and R1 nfESCs; approximately half of the genes (4490/8943) were up-regulated after parthenogenesis. Only 3276 genes were expressed differently in both comparisons, which consisted of 1878 up-regulated and 1398 down-regulated genes. In addition, total 2766 genes were up-regulated in one comparison and downregulated in another, which consisted of 1618 genes up-regulated in B6D2F1 nfESCs and down-regulated in R1 nfESCs, and 1148 genes up-regulated in R1 nfESCs and down-regulated B6D2F1 nfESCs. Thus total 6042 genes were changed after parthenogenesis, regardless of up-and down-regulation. In the second comparison employing pESCs-2, 7633 genes showed significantly different expression after parthenogenesis, while 9074 genes were expressed differently in pESCs-2 and R1 nfESCs. Total 3329 genes were expressed differently in both comparisons and 2029 genes were up-regulated in one comparison and down-regulated in another. Thus, total 5358 genes were changed after parthenogenesis, regardless of up-and down-regulation. 
Gene ontology annotation
The genes expressed differently in pESCs compared with both nfESCs were further analyzed by the percentage distribution of gene ontology. As listed in Table II , the DEGs fall into various functional categories when distributed into biological processes, molecular functions or cellular components in gene ontology term level 2. In two comparisons, an overall 88% (96/109) of the major functional genes differentially (P , 0.01) expressed in one comparison also showed the difference in the other. Eighty-nine percent (48/54) of the annotated genes listed in the first comparison set was repeatedly listed in the second comparison, while 87% (48/55) of the genes listed in the second set was listed in the first comparison.
Imprinted genes
Of those genes differentially expressed after parthenogenesis in the first comparison, 16 were imprinted genes consisting of eight paternally imprinted genes (Mcts2, Mest, Zfp264, Snrpn, Nap1l5, Impact and Dlk1 were up-regulated, whereas Igf2 was down-regulated) and eight maternally imprinted genes (Pon2, Cdkn1c, Grb10, Rian, Igf2r, Gnas, Ube3a and Phlda2 were down-regulated; Table III ). On the other hand, 15 imprinted genes consisting of eight paternally imprinted genes (Mcts2, Mest, Zfp264, Snrpn, Impact, Dlk1 and Ddc were up-regulated, whereas Igf2 was down-regulated) and seven maternally imprinted genes (Pon2, Cdkn1c, Grb10, Igf2r, Gnas, Ube3a and Phlda2, all were down-regulated) showed different expression after parthenogenesis in the second comparison. In two comparisons, however, parthenogenesis altered the expression of only nine paternally imprinting and eight maternally imprinting genes because of the similarity of the gene listing. Four imprinted genes (Snrpn, Mest, Ndn and Phlda2) which showed altered expression after parthenogenesis were randomly selected from the database, and their expression level was quantified by real-time PCR. As shown in Fig. 4 , 88% (14/16) of the microarray results was consistent with the results of mRNA quantification by real-time PCR.
Analysis of 3276 genes that were expressed differently in pESCs by reference gene network
A gene-coexpression network using the data sets derived from six tissues was constructed. Using the reference gene network, the 3276 genes up-regulated or down-regulated after parthenogenesis in the first comparison using pESC-1 were determined (Supplementary data). The hub genes were subdivided into stimulatory or inhibitory based on their promotion or repression of networked gene expression, respectively. Up to 20 up-regulated and down-regulated hub genes were ranked according to the number of correlations among genes from the following four groups; genes that are up-regulated in pESCs relative to both nfESCs and have a stimulatory correlation with other genes, genes that are up-regulated in pESCs and have an inhibitory correlation with other genes, genes that are downregulated in pESCs and have a stimulatory correlation with other genes and genes that are down-regulated in pESCs and have an inhibitory Two sets (A and B) of comparison were attempted using two lines of pESCs [pESC-1 and pESC-2 for (A) and (B), respectively]. In each set, gene expression of nfESCs derived from R1 strain was first compared with that of nfESCs derived from B6D2F1 strain. Comparisons were subsequently made between pESCs and nfESCs of the same strain (B6D2F1) and between pESCs and nfESCs of different strain (R1). In the first comparison (A), the change in gene expression after parthenogenesis was less than the change induced by strain difference, while the number of genes with altered expression was similar among all comparisons in the second set (B). correlation with other genes. As shown in Supplementary data, S2, Ndufb10, Ndufb11, Etfa, Atp5k, Idh3g, 1810013D10Rik, Ndufa11, Acyp2, Pdha1, Slc25a20, Ankrd40, Art3, Slc25a4, Deb1, Cstf2, Smyd1, Pdk3, Sec61a1, Pxmp2 and Lama2 were stimulatory hub genes, and Dazl, 5430432M24Rik, Skap2, Gltp, Slc10a3, Cggbp1, Sema5b, 1110004F10Rik, Bcap31, Etfb, Dmrtb1, Sult4a1, Grid2, Sec61a1, Nkiras1, Cstf2, Pxmp2, Dnajb5, Art3 and Sptlc2 were inhibitory hub genes, which networked with 67 -96 genes and with 28 -54 genes, respectively; these genes were listed as up-regulated and highly networked genes. In contrast, Vegfb, Fh1, 1500032D16Rik, Ogdh, Grsf1, Sdha, 2410003P15Rik, Phyh, Coq5, Myl3, Acadl, Hrc, Golga4, Spag7, Higd2a, Gbe1, Foxh1, Src, Ndrg2 and Hspb2 were stimulatory hub genes, and Arl4c, Foxh1, Elovl1, Mlycd, Cdc42se1, Runx1, Klc2, Atp1a2, Hif3a, Iqgap1, 9030612M13Rik, Hrc, Gnai3, Rbm39, Tuft1, Vegfb, Ndrg2, Litaf, Src and Zfp207 were inhibitory hub genes, which networked with 57-88 genes and with 28 -64 genes, respectively; these genes were listed as down-regulated genes (Supplementary data, S3). The hub genes that ranked within the top 20 based on their networking mainly controlled protein transport, metabolism and ATP production, whereas several development-related genes including Tuft1, Foxh1, Cdc42sel, Src, Ndrg2, Runx1 and Vegfb were either down-regulated or inhibitory to other networked genes in pESCs. Seven major genes that are considered as regulatory factors in pESCs-1 or nfESCs in the first comparison were randomly selected from the database, and their expression level was quantified. Of those genes selected, the patterns of 11 (79%) pairs from 14 total comparisons were consistent with results obtained from the DNA microarray (Supplementary data, S4 ). Lists of genes differentially expressed in each comparison are provided in Supplementary data, S5. tissue (Phillips et al., 2000; Ivanova et al., 2002; Park et al., 2002; Ramalho-Santos et al., 2002; Bhattacharya et al., 2004; Blanpain et al., 2004; Tumbar et al., 2004; Byrne et al., 2006) . ESCs derived from parthenogenesis have a homozygous genome with minimal crossover-associated heterozygosity (Kim et al., 2007) , so they can be used for autologous cell and tissue therapy. However, the molecular signature of pESCs has been poorly investigated to date. In our results, differences in the origin of ESCs (normal fertilization with spermatozoa versus parthenogenetic activation in the same strain) significantly affected the gene expression profile of ESCs; of 34 000 genes evaluated by microarray, 22.6% (7776 genes) had altered expression in pESC-1. A concomitant change of strain (B6D2F1 versus R1) with alteration of ESC origin induced further change in gene expression profile (8943 genes; 26.5% of the genes tested). However, a change of ESC strain derived from normal fertilization affected gene expression more profoundly (15 750 gene probes; equivalent to 10 414 genes; 30.6% of the genes tested). In the second comparison using pESC-2, the change in gene expression after parthenogenesis was similar to that between strains. These results suggest that the alteration of gene expression induced by parthenogenesis is similar to, or quantitatively less, than that induced by strain differences. Parthenogenesis may therefore be less likely to affect the clinical feasibility of using ESCs for autologous cell therapy than genetic background. This suggestion was supported by statistical analysis to evaluate correlation coefficient. Our previous results showing that no significant difference in stem cell characteristics, including self-renewal and differentiation, was detected in pESCs when compared with nfESCs also supported this hypothesis.
Discussion
Parthenogenesis-derived ESCs are generated from homozygous embryos consisting only of a diploid female genome. It has been reported that the absence of paternal alleles in parthenotes results in the loss of paternally imprinted genes, which may restrict the development of parthenogenetic embryos (Kaufman et al., 1977; Barton et al., 1984) . We, however, paradoxically detected expression of 17 paternally imprinted genes (Mcts2, Mest, Nap1l5, Peg3, Usp29, Zfp264, Snrpn, Ndn, Mkrn3, Peg12, Impact, Dlk1, Nnat, Slc38a4, Ins1, Nespas and Ddc) in pESCs. Our results are consistent with previous results (Jiang et al., 2007) finding expression of the paternally imprinted genes Snrpn, U2af1-rs1, Peg3, Impact, Zfp127, Dlk1 and Mest in parthenogenesis-derived ESCs. pESCs in various species have been established to date (Allen et al., 1994; Cibelli et al., 2002; Fang et al., 2006; Revazova et al., 2007; Sritanaudomchai et al., 2007) and in some species, paternally imprinted genes are expressed in pESCs. From these results, aberrant expression of paternally imprinted genes after parthenogenesis may have little or no effect on ESC establishment and self-renewal in specific lines. Otherwise, transcription activity of paternally imprinted genes may be modified to adversely affect embryo development after parthenogenesis.
We utilized FDR levels to compare the change of gene expression after parthenogenesis, which has generally been used for statistical analyzing of microarray data. An FDR level ,0.05 was equivalent to 1.2-to 1.4-fold difference in the strength of gene expression in our statistical analysis. Employing this system, we obtained 83% similarity between microarray and qRT-PCR, a level which was quite acceptable compared with other reports employing bioinformatics tool (Bhattacharya et al., 2005; Goossens et al., 2007; Ushizawa et al., 2007) . The mRNA levels for Dazl, Vegfb,and Foxh1 detected by qRT-PCR analysis did not match the microarray data, showing a 2.5-, 1.4-and 1.8-fold difference after parthenogenesis, respectively. If the significance level of the FDR is adjusted for detecting more than a 2-fold difference, the matching rate become significantly higher.
In this study, the two strains of nfESC were derived from blastocysts growing in vivo, while pESCs originated from an in vitro-culture system. Therefore, differences between in vivo and in vitro growth of embryos may interfere with determining the net effect of parthenogenesis on gene expression profile. Considering previous work reporting similar gene expression between in vivo-derived and in vitro-derived blastocysts (Whitworth et al., 2005) , however, such a difference may only minimally affect the results obtained in this study. A report from Giritharan et al. (2007) demonstrated that the difference in gene expression between in vivo-growing and in vitro-growing blastocysts was not as great as that between in vivo-fertilized and in vitro-fertilized blastocysts. It is possible that the variation in expression of the hub genes found when comparing nfESCs of different strains is simply part of the natural variation between ESC lines. From a different viewpoint, it is possible that a greater change in gene expression may be induced by parthenogenesis under a different genetic background from B6D2F1.
We used two lines of ESC derived from parthenogenetic activation for DNA microarray analysis, and the use of only two lines limits the final conclusions from this study. Nevertheless, we carefully conclude that parthenogenesis consistently influences the expression of certain imprinted genes. This hypothesis is supported by the fact that the difference between gene expression of nfESCs and that of pESC was constant in all comparisons and that expression pattern of each pESC is very similar. It is possible that these imprinted genes, changing their expression after parthenogenesis, may be the key for elucidating the functional alteration of parthenogenesis-derived stem cells. The importance of imprinted genes for understanding characterization of parthenogenetic ESCs has been raised (Jiang et al., 2007) .
In conclusion, we found alteration of gene expression in ESCs after parthenogenesis, but this was either similar to, or less than, that observed after a change of strain without altering the derivation of ESCs under a certain genetic environment. Accordingly, these results may imply that the same protocol utilized for nfESCs can be applied for pESCs. For evaluating the feasibility of use of pESCs, however, it is necessary to further examine the function of the imprinted genes with altered expression in every case of parthenogenesis. Large-scale experiments using multiple lines of pESC may also be required. The analytical system developed from this study may be useful for monitoring the clinical feasibility of various autologous stem cells, such as induced pluripotent stem cells (Revazova et al., 2007; Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008) , as well as pESCs. These genes were randomly selected from the lists of paternally-imprinted genes and both pESC-1 and pESC-2 were provided for this analysis. Triplicate PCRs were conducted for each gene and the relative value compared with two nfESCs is shown. In general, similar results from microarray Genechip data and real-time PCR were obtained from 14 (88%) of 16 comparison groups.
